Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.
Fasano GA, Bayard S, Chen Y, Varella L, Cigler T, Bensenhaver J, Simmons R, Swistel A, Marti J, Moore A, Andreopoulou E, Ng J, Brandmaier A, Formenti S, Ali H, Davis M, Newman L. Fasano GA, et al. Among authors: formenti s. Breast Cancer Res Treat. 2022 Feb;192(1):163-173. doi: 10.1007/s10549-021-06481-4. Epub 2022 Jan 13. Breast Cancer Res Treat. 2022. PMID: 35022867
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K, Teplinsky E, Silvera D, Valeta-Magara A, Arju R, Giashuddin S, Sarfraz Y, Alexander M, Darvishian F, Levine PH, Hashmi S, Zolfaghari L, Hoffman HJ, Singh B, Goldberg JD, Hochman T, Formenti S, Esteva FJ, Moran MS, Schneider RJ. Jhaveri K, et al. Among authors: formenti s. Clin Breast Cancer. 2016 Apr;16(2):113-22.e1. doi: 10.1016/j.clbc.2015.11.006. Epub 2015 Dec 1. Clin Breast Cancer. 2016. PMID: 26774497 Free PMC article.
Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.
Fasano GA, Bayard S, Tamimi R, Bea V, Malik M, Davis M, Simmons R, Swistel A, Marti J, Drotman M, Katzen J, Formenti S, Ng J, Astrow A, Taiwo E, Balogun O, Siegel B, Radzio A, Elreda L, Chen Y, Newman L. Fasano GA, et al. Among authors: formenti s. Am J Surg. 2022 Oct;224(4):1039-1045. doi: 10.1016/j.amjsurg.2022.05.037. Epub 2022 May 27. Am J Surg. 2022. PMID: 35641320 Free PMC article.
MRI-LINAC: A transformative technology in radiation oncology.
Ng J, Gregucci F, Pennell RT, Nagar H, Golden EB, Knisely JPS, Sanfilippo NJ, Formenti SC. Ng J, et al. Among authors: formenti sc. Front Oncol. 2023 Jan 27;13:1117874. doi: 10.3389/fonc.2023.1117874. eCollection 2023. Front Oncol. 2023. PMID: 36776309 Free PMC article. Review.
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
Singh J, Novik Y, Stein S, Volm M, Meyers M, Smith J, Omene C, Speyer J, Schneider R, Jhaveri K, Formenti S, Kyriakou V, Joseph B, Goldberg JD, Li X, Adams S, Tiersten A. Singh J, et al. Among authors: formenti s. Breast Cancer Res. 2014 Mar 31;16(2):R32. doi: 10.1186/bcr3634. Breast Cancer Res. 2014. PMID: 24684785 Free PMC article. Clinical Trial.
Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.
Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J. Ahmed MM, et al. Among authors: formenti s. Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. Cancer Res. 2018. PMID: 29686020 Free PMC article. No abstract available.
329 results